Beijing Tong Ren Tang Chinese Medicine Company Limited

HKSE 3613.HK

Beijing Tong Ren Tang Chinese Medicine Company Limited Net Cash Used For Investing Activities for the year ending December 31, 2023: USD -138.08 M

Beijing Tong Ren Tang Chinese Medicine Company Limited Net Cash Used For Investing Activities is USD -138.08 M for the year ending December 31, 2023, a -421.60% change year over year. Net cash used for investing activities is total cash inflows and outflows related to activities intended to generate future income and cash flows from investments.
  • Beijing Tong Ren Tang Chinese Medicine Company Limited Net Cash Used For Investing Activities for the year ending December 31, 2022 was USD 42.94 M, a 226.00% change year over year.
  • Beijing Tong Ren Tang Chinese Medicine Company Limited Net Cash Used For Investing Activities for the year ending December 31, 2021 was USD -34.08 M, a -152.15% change year over year.
  • Beijing Tong Ren Tang Chinese Medicine Company Limited Net Cash Used For Investing Activities for the year ending December 31, 2020 was USD 65.34 M, a -39.06% change year over year.
  • Beijing Tong Ren Tang Chinese Medicine Company Limited Net Cash Used For Investing Activities for the year ending December 31, 2019 was USD 107.22 M, a 240.47% change year over year.
Key data
Date Net Cash Used For Investing Activities Net Cash Used Provided By Financing Activities Dividends Paid Capital Expenditure
Market news
Loading...
SV Wall Street
HKSE: 3613.HK

Beijing Tong Ren Tang Chinese Medicine Company Limited

Description

Beijing Tong Ren Tang Chinese Medicine Company Limited, together with its subsidiaries, engages in the manufacture, retail, and wholesale of Chinese medicine and healthcare products to wholesalers and individuals. The company operates through three segments: Hong Kong, Mainland China, and Overseas. It also offers Chinese medical consultation and treatment services. The company operates 23 retail outlets in Hong Kong and 46 retail outlets in other countries and regions in Asia, Oceania, North America, and Europe. It markets its products under the Tong Ren Tang brand. The company was founded in 1669 and is based in Wan Chai, Hong Kong.

Similar companies

3692.HK

Hansoh Pharmaceutical Group Company Limited

USD 2.28

1.94%

1666.HK

Tong Ren Tang Technologies Co. Ltd.

USD 0.63

-1.24%

3320.HK

China Resources Pharmaceutical Group Limited

USD 0.67

1.15%

StockViz Staff

February 3, 2025

Any question? Send us an email